Back

Time for a new destination: foregoing surgical sympathectomy after successful stellate ganglion block in patients with refractory ventricular tachycardia

28 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Treatment of life-threatening arrhythmias and cardiac arrest Clinical ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Cicely Dye

Naval Medical Centre San Diego, San Diego (United States of America)

8 More presentations in this session

Presentation thumbnail
Artemisinin combined with low dose quinidine suppresses ventricular tachyarrhythmia in a model of Brugada syndrome
Doctor H. Jeong (Iksan, KR)
Abstract Slides Video
Presentation thumbnail
Single beta-blocker or combined amiodarone therapy in ICD and CRT-D patients - Insights from the German DEVICE-registry
Doctor F. Wiedmann (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of percutaneous left stellate ganglion block in patients with refractory electrical storm: our five years experience.
Doctor S. Compagnoni (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study
Ms G. Monachino (Lugano, CH)
Abstract Slides Video
Presentation thumbnail
Does the type of mechanical chest compressor affect resuscitation outcome of out of hospital cardiac arrest patients? A propensity-score based comparison of three devices.
Doctor S. Savastano (Pavia, IT)
Abstract Slides

Access the full session

Session thumbnail
Treatment of life-threatening arrhythmias and cardiac arrest

The Event

Event poster

ESC Congress 2023

28 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of percutaneous left stellate ganglion block in patients with refractory electrical storm: our five years experience.
thumbnail
Congress Presentation
Clinical profile of patients undergoing percutaneous stellate ganglion block for electrical storm and association with antiarrhythmic efficacy
thumbnail
Congress Presentation
The concomitant treatment with antiarrhythmic drugs do not influence the efficacy of percutaneous stellate ganglion block in patients with electrical storms. New insights from the STAR study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources